US FDA authorizes Pfizer’s coronavirus vaccine for emergency use

Dhwani Mehta FXStreet

The US Food and Drug Administration (FDA) announced the much-awaited authorization of Pfizer and BioNTech's jointly developed coronavirus vaccine for emergency use (EUA) late Friday.

This comes after the vaccine advisers to the US medical regulator voted 17 to 4 Thursday, recommending the approval of the vaccine for emergency use.

Pfizer’s covid vaccine, which has shown 95% efficacy in a late-stage trial, will be available for the first inoculations early next week. Canada also authorized the vaccine and expects to start inoculations next week.

Additional details

“The FDA said the vaccine can be given to people aged 16 and older.”

“Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients of the first round of 2.9 million doses.”

In response to the FDA authorization, US President Donald Trump posted a video on Twitter, citing, “the first vaccine will be administered in less than 24 hours.”

pic.twitter.com/ofLq3OMicv
— Donald J. Trump (@realDonaldTrump) December 12, 2020

Author

Dhwani Mehta

FXStreet

Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.

GBP/USD extends the drop to 1.3360

GBP/USD builds on Monday’s decline and briefly clinches five-day lows near 1.3360 on Tuesday. Cable’s extra pullback follows the better tone in the Greenback as uncertainty in the Middle East prompts investors to adopt a cautious stance. Meanwhile, an apathetic UK labour market report also collaborates with the selling pressure on the British Pound.

EUR/USD holds gains above 1.1400 on hawkish ECB expectations despite US-Iran tensions

The EUR/USD pair trades with mild gains around 1.1405 during the early Asian session on Wednesday. A hawkish tone from the European Central Bank provides some support to the Euro against the US Dollar. Traders await the upcoming ECB interest rate decision on Thursday.

Gold: Strong recovery might face roadblock as oil price extends gains

Gold price extends its winning streak for the third trading day on Wednesday, trading 1.5% higher to near $4,140 during the Asian session. The precious metal recovered strongly in the past few trading days from its three-week low of $3,959.80 as traders scaled back Federal Reserve’s interest rate hike expectations for the monetary policy meeting next week.

The market runs back into AI despite higher Oil and yields

World stocks surged as traders made a spirited return to the market’s commanding centre of gravity, piling back into semiconductors, AI leaders and momentum, with the enthusiasm of a crowd rushing through the one door it still trusts. The Nasdaq led Wall Street higher, semiconductor shares jumped more than 5%, and momentum staged its strongest rebound in years.

The Iranian war has again risen

The Iranian war has again risen to the top of the economics factor list. There is no end in sight. Intelligence experts say the current level of offense/retaliation will not change minds in Tehran, while in Washington, Trump fears all-out war, which would mean boots on the ground.

US Dollar mid-year outlook: Exceptional currency, exceptional risks?

The US Dollar enters the second half of 2026 in a markedly different position from a year ago. The King currency has recovered, reflecting persistent US inflation, changing expectations for Fed policy, geopolitical tensions and renewed demand for defensive assets.